Industry News

NLS method for diagnosing gastric and colon cancer

The non-linear diagnostic method (NLS) using the M etatron 4025 Hunter has recently been actively implemented in many medical institutions. The most tangible results were achieved by using the NLS method as a means of idpensary observation. In the course of its development and progress, the method has become the most important tool in the diagnosis and monitoring of many widespread disorders of the digestive organs: it facilitates a rapid and detailed understanding of lesions and their patterns, and helps to assess the effectiveness of treatments. This was found in our studies of a range of diseases, including gastroduodenal ulcers, chronic gastritis, and benign and malignant gastric and colon tumours. The specific characteristics and working conditions of Russian therapeutic and clinical institutions allow the widespread use of the NLS methodology, not only for the diagnosis of the presence of certain symptoms, but also for drug monitoring. Importantly, speed and low cost make NLS information available to many patients. Physicians can now evaluate patients for underlying changes that can only be verified with NLS. Specifically, such patients include patients with precancerous diseases or mucus disorders in the upper and/or lower part of the digestive tract and patients with tumors that are still latent at a certain stage.

According to data obtained by some medical experts using this device for NLS diagnosis and based on studies of thousands of cases per year, the frequency of detection of localized or diffuse changes, the frequency of chronic atrophic gastritis in a typical patient over 50 years old is 30- Within 40%. Spectroscopic analysis of different parts of the pattern of focal changes in the gastric mucosa revealed that different symptoms of diseases including intestinal metaplasia and epithelial dysplasia can be frequently detected in them. During the NLS analysis period, gastric ulcer symptoms were present in approximately 5% of cases, gastric polyps in 7% of cases, and colonic polyps in 45% of cases. Therefore, the results of the NLS analysis alone (without regard to other risk factors) indicated that the majority of patients in each age group appeared to be those requiring active observation for underlying gastric cancer (GC) or colon cancer (CC). ).

Two very important factors are known to be crucial for malignant disease diagnosis: the quality of the clinical and diagnostic technique and the specific pattern of disease progression, which actually determines the dynamics of disease progression. The diagnostic data for gastric cancer and colon cancer may be considered optimal to a certain extent, taking into account the capacity and working conditions of the treating institutions. This means that even though all patients are susceptible to being diagnosed with the disease during medical observation (actually a 60% problem), stage 1 conditions may be detected in only 40% of patients. Analysis of the reasons for delayed diagnosis of cases shows that such cases can be prevented through improved organization and methodical work.

Therefore, the NLS of Metatron 4025 Hunter can be considered as an appropriate method for the diagnosis of gastric and colon cancer. Difficulties in handling NLS interpretation are mainly related to the initial phase, and in the long run, the frequency of disease detection depends on the physician's enthusiasm for spectroscopic verification of any focal changes in the mucosa.